Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Q4 2020 Earnings Conference Call February 09, 2021, 16:30 PM ET Company Participants Jen Robinson - Vice President, Investor Relations Steven...
Shares of Deciphera Pharmaceuticals (NASDAQ:DCPH) were unchanged in after-market trading after the company reported Q4 results.
Quarterly Results
Earnings ...
Deciphera Pharmaceuticals, Inc. (DCPH) delivered earnings and revenue surprises of 5.17% and 4.32%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Feb. 9) Abbott ...
Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO ...
Deciphera Pharmaceuticals, Inc. DCPH today announced that Steve Hoerter, President and Chief Executive Officer, will participate in a fireside chat at the